
Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy
Author(s) -
T. Konno,
D. Chen,
L. Wang,
H. Wakimoto,
P. Teekakirikul,
M. Nayor,
M. Kawana,
S. Eminaga,
J. M. Gorham,
K. Pandya,
O. Smithies,
F. J. Naya,
E. N. Olson,
J. G. Seidman,
C. E. Seidman
Publication year - 2010
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/01f1-e160
Subject(s) - mef2 , myocyte , hypertrophic cardiomyopathy , medicine , cardiology , cardiomyopathy , enhancer , biology , heart failure , transcription factor , genetics , gene